Clinical Trials Browser

Urinary Bladder Neoplasms, Carcinoma, Transitional Cell, Uterine Cervical Neoplasms, Head and Neck Neoplasms, Liver Neoplasms, Lung Neoplasms, Nasopharyngeal Neoplasms, Ovarian Neoplasms, Prostatic Neoplasms, Thyroid Neoplasms, Endometrial Neoplasms, Cholangiocarcinoma

NCT04669496 2025-09-04

Phase II-III Clinical Trial of PD1 Antibody (Toripalimab), Lenvatinib and GEMOX Neoadjuvant Treatment for Resectable Intrahepatic Cholangiocarcinoma With High-risk Recurrence Factors

Phase 2/3 Active not recruiting

178 enrolled

Gastrointestinal

Cholangiocarcinoma

NCT06355427 2025-04-11

FAPIChol

Phase 2/3 Recruiting

81 enrolled

Gastrointestinal

Cholangiocarcinoma

NCT06923475 2025-04-11

NEODISCO

Phase 2/3 Not yet recruiting

150 enrolled

Gastrointestinal

Cholangiocarcinoma, Klatskin Tumor

NCT06037980 2025-02-17

PURITY

Phase 2/3 Recruiting

300 enrolled

Gastrointestinal

Biliary Tract Neoplasms, Cholangiocarcinoma

NCT02108145 2019-08-01

Percutaneous Bilateral Versus Unilateral Metal Stent for Hilar Cholangiocarcinoma

Phase 2/3 Unknown

70 enrolled

Gastrointestinal

Jaundice, Cholangiocarcinoma, Klatskin Tumor

NCT02482454 2017-08-01

Radiofrquency Ablation Combined With Cytokine-induced Killer Cells for the Patients With Cholangiocarcinoma

Phase 2/3 Active not recruiting

50 enrolled

Gastrointestinal

Cholangiocarcinoma

NCT01755013 2017-02-20

Photodynamic Therapy (PDT) for Palliation of Cholangiocarcinoma

Phase 2/3 Unknown

55 enrolled

Gastrointestinal

Bile Duct Neoplasms, Cholangiocarcinoma

NCT01739465 2013-02-26

Comparison of Endoscopic Radiofrequency Ablation Versus Photodynamic Therapy for Inoperable Cholangiocarcinoma

Phase 2/3 Unknown

120 enrolled

Gastrointestinal

Adenocarcinoma, Bile Duct Diseases, Biliary Tract Diseases, Carcinoma, Constriction, Pathologic, Digestive System Diseases, Neoplasms, Neoplasms by Site, Cholangiocarcinoma

Clinical Trials

Trop2-targeted immunoPET Imaging of Solid Tumors

Phase II-III Clinical Trial of PD1 Antibody (Toripalimab), Lenvatinib and GEMOX Neoadjuvant Treatment for Resectable Intrahepatic Cholangiocarcinoma With High-risk Recurrence Factors

FAPIChol

NEODISCO

PURITY

Percutaneous Bilateral Versus Unilateral Metal Stent for Hilar Cholangiocarcinoma

Radiofrquency Ablation Combined With Cytokine-induced Killer Cells for the Patients With Cholangiocarcinoma

Photodynamic Therapy (PDT) for Palliation of Cholangiocarcinoma

Comparison of Endoscopic Radiofrequency Ablation Versus Photodynamic Therapy for Inoperable Cholangiocarcinoma